Navigation Links
Bioabsorbable Stents - Global Strategic Business Report - 2013 Profiles 16 Companies inside the Market
Date:6/7/2013

DUBLIN, June 7, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/j6pgb5/bioabsorbable) has announced the addition of the "Bioabsorbable Stents - Global Strategic Business Report" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)


This report analyzes the worldwide markets for Bioabsorbable Stents in Thousand Units. The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2018. The report profiles 16 companies including many key and niche players such as Abbott Laboratories, Amaranth Medical, Inc., Arterial Remodeling Technologies SA, BIOTRONIK SE & Co. KG, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., and REVA Medical, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. Executive Summary

1. INDUSTRY OVERVIEW

2. PRODUCT OVERVIEW

3. PRODUCT LAUNCH/INTRODUCTION
4. RECENT INDUSTRY ACTIVITY

5. FOCUS ON SELECT GLOBAL PLAYERS

6. GLOBAL MARKET PERSPECTIVE

III. MARKET

1. THE UNITED STATES

2. EUROPE
3. ASIA-PACIFIC
4. REST OF WORLD

IV. COMPETITIVE LANDSCAPE


Companies Mentioned

- 3D Biotek LLC (USA)
- Abbott Laboratories (USA)
- Abbott Vascular (USA)
- Amaranth Medical, Inc. (USA)
- Arterial Remodeling Technologies SA (France)
- Arterius Ltd. (UK)
- Biotronik SE & Co., KG (Germany)
- Elixir Medical Corporation (USA)
- Kyoto Medical Planning Co., Ltd. (Japan)
- OrbusNeich (Hong Kong)
- REVA Medical, Inc. (USA)
- S3V Vascular Technologies Pvt., Ltd. (India)
- Sahajanand Medical Technologies Pvt., Ltd. (India)
- Stron Medical (Germany)
- Tepha, Inc. (USA)
- Xenogenics Corporation (USA)
- Zorion Medical (USA)


For more information visit http://www.researchandmarkets.com/research/j6pgb5/bioabsorbable

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Sector: Cardiovascular Devices


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. OrbusNeich Launches Worlds First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents
2. Peripheral Vascular Devices Market (Peripheral Vascular Stents, PTA Balloon Catheters, Guidewires, IVC Filters, Atherectomy, Chronic Total Occlusion, Embolic Protection Devices, Synthetic Surgical Grafts, Aortic Stents) - Global Industry Analysis, S
3. Global Vascular Stents Market 2012-2016
4. Drug-coated stents prevent leg amputation
5. Largest Prospective Study Shows IVUS-Guided Stent Placement Improves Patient Outcomes with Current Generation of Stents
6. U.S. Physician Survey: Stents by Brand, Length, Diameter, Type and Coating 2012
7. Global Drug-Eluting Stents Industry
8. Lexicon To Present At The Goldman Sachs Global Healthcare Conference
9. BD to Present at the Goldman Sachs 34th Annual Global Healthcare Conference
10. Quest Diagnostics CEO Steve Rusckowski Reaffirms Full-Year 2013 Guidance At The Jefferies 2013 Global Healthcare Conference
11. Frost & Sullivan: Standardized Regulations Crucial for Growth in Global Dimensional Metrology Market for Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... , May 3, 2016 According ... Size, Share, Development, Growth and Demand Forecast to 2022 ... Field Strength (High Field, Very High Field, Low to ... Head and Neck, Spine, Musculoskeletal, Vascular, Breast, Pelvic and ... magnetic resonance imaging (MRI) market was valued at $5,351.7 ...
(Date:5/3/2016)... 3, 2016 Norgine ... sie einen entscheidenden Meilenstein durch diese Veröffentlichung ... zum Handeln, um Patientenresultate  bei Verdauungs- und ... Fortschritten im Verständnis der Hepatischen Enzephalopathie bei ... für Hepatische Enzephalopathie in der Öffentlichkeit zu ...
(Date:5/2/2016)... , May 2, 2016  Celsion Corporation (NASDAQ: ... today announced data from the first cohort of ... trial (the OVATION Study) combining GEN-1, the Company,s ... the treatment of newly-diagnosed patients with advanced ovarian ... interval debulking surgery.  In the first three patients ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... May 05, 2016 , ... The talus is the part ankle ... falls, or traffic accidents can cause the talus bone to be fractured, and a ... In a first-of-its-kind procedure using 3D printing technology, internationally renowned orthopedic surgeon Dr. ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... announces the Everlasting Glove, a sports invention that aids in the improvement of ... Manufacturing industry is worth $9 billion," says Scott Cooper, CEO and Creative Director ...
(Date:5/4/2016)... ... 2016 , ... Trinity Health today launched its inaugural Innovation ... at improving care and reducing readmission rates for patients who are dually eligible ... is to drive innovation that transforms our ministry and our industry to be ...
(Date:5/4/2016)... AZ (PRWEB) , ... May 04, 2016 , ... ... Annual Technology & Business Conference. The conference opened on Tuesday with Frank Luntz, ... discussion on NCPDP’s PDMP Solution provided a deep dive on NCPDP’s model solution ...
(Date:5/4/2016)... , ... May 04, 2016 , ... Level 10 Head ... her verbal commitment to the University of Arizona for the fall of 2019. ... decision last month. Brovedani’s commitment to the GymCats came from her connection with the ...
Breaking Medicine News(10 mins):